1. Section on Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD;
2. Office of Rare Disease Research, Office of the Director, NIH, Bethesda, MD;
3. Institute of Human Genetics, Western Galilee Hospital, Naharia, Israel;
4. Pediatric Hematology Unit, Hacettepe University Children's Hospital, Ankara, Turkey;
5. Department of Computer Sciences, Technion, Israel Institute of Technology, Haifa, Israel;
6. Department of Hematology, Western Galilee Hospital, Naharia, Israel;
7. Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey;
8. Division of Pediatric Hematology/Oncology, Penn State Hershey Children's Hospital, Hershey, PA;
9. Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD;
10. Department of Anaesthesiology and Intensive Care, Experimental and Clinical Haemostasis, University Hospital Münster, Münster, Germany;
11. NIH Intramural Sequencing Center, NIH, Bethesda, MD;
12. Genome Technology Branch, NIH, Bethesda, MD;
13. Centre de Reference des Pathologies Plaquettaires, Plateforme Technologique et d'Innovation Biomedicale, Hopital Xavier Arnozan, Pessac, France;
14. Department of Laboratory Medicine, University of Minnesota, Minneapolis, MN; and
15. Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel